{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:12Z","timestamp":1792730292128,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Around 30% of survivors of invasive meningococcal disease (IMD) may develop long-term sequelae; data from Latin America remain scarce. This study aimed to estimate the proportion of long-term sequelae in pediatric IMD survivors and associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study with cross-sectional outcome evaluation included children diagnosed with IMD (2009\u20132019) in 2 hospitals in Santiago, Chile. Between October 2022 and April 2023, 40 IMD survivors and 42 age- and sex-matched children without IMD or central nervous system infection underwent standardized physical, neurocognitive, audiologic and functional assessments conducted independently. Prevalence ratio (PR) and adjusted PR (aPR) were estimated with modified Poisson regression with standard errors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Median ages were 10 (interquartile range [IQR] 9\u201313) and 11 (IQR 9\u201314) years in the exposed and unexposed groups; 70% and 64.3% were male. Sequelae occurred in 70% of exposed; the corresponding clinical findings were present in 16.7% of unexposed children (PR, 4.20; 95% confidence interval [CI]: 2.07\u20138.51). Neurologic (55%), dermatologic (25.0%) and hearing (20.5%) sequelae predominated. This association remained significant after adjusting for age, sex, caregiver education and socioeconomic status (aPR, 3.75; 95% CI: 1.83\u20137.69). Children with sequelae had a lower quality of life than those without sequelae (62% and 8%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Pediatric survivors of IMD in Chile face a high burden of long-term sequelae. Sustained multidisciplinary follow-up and preventive strategies, including vaccination, are essential to reduce disability and improve quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005442","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:01:31Z","timestamp":1792728091000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Sequelae in Children With Invasive Meningococcal Disease, Chile 2009\u20132023"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1387","authenticated-orcid":false,"given":"Rodolfo","family":"Villena","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Infectious Disease Unit, Hospital Dr. Exequiel Gonz\u00e1lez Cort\u00e9s, Santiago, Chile"},{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Exequiel Gonz\u00e1lez Cort\u00e9s, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4626-3629","authenticated-orcid":false,"given":"Cindy","family":"Arteta-Acosta","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Luis Calvo Mackenna, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00e9","family":"Bahamondes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Luis Calvo Mackenna, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9725-7686","authenticated-orcid":false,"given":"Romina","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Luis Calvo Mackenna, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7340-7807","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Sep\u00falveda-Aliaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Infectious Disease Unit, Hospital Dr. Exequiel Gonz\u00e1lez Cort\u00e9s, Santiago, Chile"},{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Exequiel Gonz\u00e1lez Cort\u00e9s, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1492-6456","authenticated-orcid":false,"given":"Eduardo","family":"Cifuentes-Silva","sequence":"additional","affiliation":[{"name":"Faculty of Medical Science, School of Kinesiology, Universidad de Santiago de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Mascar\u00f3","sequence":"additional","affiliation":[{"name":"School Integration Program, Corporaci\u00f3n de Desarrollo, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Falconi","sequence":"additional","affiliation":[{"name":"Medical Affairs, Vaccine, Pfizer Inc, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Medical Affairs and Evidence Generation, Pfizer Inc, Collegeville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Findlow","sequence":"additional","affiliation":[{"name":"Global Vaccine Medical Affairs, Pfizer Ltd, Dunkinfield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-002X","authenticated-orcid":false,"given":"Mar\u00eda E.","family":"Santolaya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, CICA Hospital Dr. Luis Calvo Mackenna, Universidad de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"R1-20261023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents.","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet (London, England)"},{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2016.03.041","article-title":"Deciphering the burden of meningococcal disease: conventional and under-recognized elements.","volume":"59","author":"Martin\u00f3n-Torres","year":"2016","journal-title":"J Adolesc Health"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","article-title":"Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"Zunt","year":"2018","journal-title":"Lancet Neurol"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","article-title":"Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.","volume":"11","author":"Viner","year":"2012","journal-title":"Lancet Neurol"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/cc9087","article-title":"Surviving meningococcal septic shock in childhood: long-term overall outcome and the effect on health-related quality of life.","volume":"14","author":"Buysse","year":"2010","journal-title":"Crit Care"},{"key":"R6-20261023","first-page":"521","article-title":"Meningococcal vaccines: WHO position paper, November 2011.","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis.","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R8-20261023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/INF.0000000000003560","article-title":"Sequelae at hospital discharge in 61 children with invasive meningococcal disease, Chile, 2009\u20132019.","volume":"41","author":"Arteta-Acosta","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/INF.0000000000004962","article-title":"Long-term impact of invasive meningococcal disease in Australian adolescents and young adults.","volume":"45","author":"McMillan","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/INF.0000000000002908","article-title":"Psychiatric disabilities and other long-term consequences of childhood bacterial meningitis.","volume":"40","author":"Johansson Kostenniemi","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7764\/psykhe.2020.21793","article-title":"Estandarizaci\u00f3n Chilena de la Escala Wechsler de Inteligencia para Ni\u00f1os - Quinta Edici\u00f3n.","volume":"31","author":"Rosas","year":"2022","journal-title":"Psykhe (Santiago)"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"e0201033","DOI":"10.1371\/journal.pone.0201033","article-title":"Normative data for handgrip strength in children and adolescents in the Maule Region, Chile: evaluation based on chronological and biological age.","volume":"13","author":"G\u00f3mez-Campos","year":"2018","journal-title":"PLoS One"},{"key":"R16-20261023","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4067\/S0034-98872012000800007","article-title":"Valores de referencia del test de marcha de seis minutos en ni\u00f1os sanos.","volume":"140","author":"Gatica","year":"2012","journal-title":"Rev M\u00e9d Chile"},{"key":"R17-20261023","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/09638288.2011.607217","article-title":"Computer adaptive test performance in children with and without disabilities: prospective field study of the PEDI-CAT.","volume":"34","author":"Dumas","year":"2012","journal-title":"Disabil Rehabil"},{"key":"R18-20261023","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQLTM 4.0: reliability and validity of the pediatric quality of life inventoryTM version 4.0 generic core scales in healthy and patient populations.","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"2021764","DOI":"10.1080\/21645515.2021.2021764","article-title":"Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.","volume":"18","author":"Weil-Olivier","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"R20-20261023","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12889-022-12933-3","article-title":"Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017\u2014a secondary database analysis.","volume":"22","author":"Guedes","year":"2022","journal-title":"BMC Public Health"},{"key":"R21-20261023","doi-asserted-by":"crossref","DOI":"10.1093\/fampra\/cmad062","article-title":"Epidemiology of invasive meningococcal disease and its sequelae: a population-based study in Italian primary care, 2000-2019.","volume":"42","author":"Lapi","year":"2025","journal-title":"Fam Pract"},{"key":"R22-20261023","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","article-title":"Range of invasive meningococcal disease sequelae and health economic application\u2014a systematic and clinical review.","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Public Health"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"e0267786","DOI":"10.1371\/journal.pone.0267786","article-title":"A database study of clinical and economic burden of invasive meningococcal disease in France.","volume":"17","author":"Huang","year":"2022","journal-title":"PLoS One"},{"key":"R24-20261023","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/INF.0000000000001048","article-title":"The burden of pediatric invasive meningococcal disease in Spain (2008\u20132013).","volume":"35","author":"Rivero-Calle","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1542\/peds.2008-0581","article-title":"Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study.","volume":"123","author":"Borg","year":"2009","journal-title":"Pediatrics"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1001\/jama.2013.3792","article-title":"Educational achievement and economic self-sufficiency in adults after childhood bacterial meningitis.","volume":"309","author":"Roed","year":"2013","journal-title":"JAMA"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.anpedi.2015.12.001","article-title":"Enfermedad meningoc\u00f3cica invasiva en Navarra en la era de la vacuna conjugada antimeningoc\u00f3cica C.","volume":"86","author":"Morales","year":"2017","journal-title":"Anales de Pediatr\u00eda"},{"key":"R28-20261023","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1080\/21645515.2021.1996808","article-title":"Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.","volume":"17","author":"Gra\u00f1a","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"R29-20261023","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/14760584.2022.2052048","article-title":"Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.","volume":"21","author":"Taha","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"R30-20261023","doi-asserted-by":"crossref","first-page":"2406613","DOI":"10.1080\/21645515.2024.2406613","article-title":"Inequalities in the risk and prevention of invasive meningococcal disease in the United States\u2014a systematic literature review.","volume":"20","author":"Begum","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R31-20261023","doi-asserted-by":"crossref","first-page":"126155","DOI":"10.1016\/j.vaccine.2024.126155","article-title":"The quality-adjusted life-years loss due to serogroup B invasive meningococcal disease in Spain.","volume":"42","author":"Garc\u00eda","year":"2024","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:01:35Z","timestamp":1792728095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005442","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"2026-05-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}